During this session, the panelists discussed notable developments within the life sciences industry with a specific focus on the GLP-1 drug market and its opportunities for improvement in patient satisfaction and dosage. They also focused on recent increased deal activity and creativity within the MedTech industry while monitoring mid-tier deals in other areas of biopharma.
Read the full article: Key Takeaways | State of the Life Sciences Market – Still Looking for an Exit //
Source: https://www.mwe.com/insights/key-takeaways-state-of-the-market-still-looking-for-an-exit/